Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -259,581 | -191,184 | -132,613 | -69,595 | -197,556 |
| Depreciation Amortization | 3,005 | 1,178 | 495 | 202 | -2,252 |
| Accounts payable and accrued liabilities | -2,964 | 9,168 | -7,096 | -7,768 | 12,706 |
| Other Working Capital | 2,983 | 11,910 | 6,914 | -7,181 | 10,008 |
| Other Operating Activity | 51,423 | 26,486 | 30,373 | 19,050 | 18,205 |
| Operating Cash Flow | $-205,134 | $-142,442 | $-101,927 | $-65,292 | $-158,889 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -271,062 | -353,150 | -318,039 | 100,742 | 96,942 |
| PPE Investments | -46,791 | -23,456 | -5,612 | -637 | -6,917 |
| Investing Cash Flow | $-317,853 | $-376,606 | $-323,651 | $100,105 | $90,025 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 6,704 | N/A | N/A | N/A |
| Common Stock Issued | 9,663 | 567,043 | 572,581 | 3,951 | 6,443 |
| Other Financing Activity | 566,759 | -283 | -283 | -118 | -312 |
| Financing Cash Flow | $576,422 | $573,464 | $572,298 | $3,833 | $6,131 |
| Beginning Cash Position | 19,419 | 19,419 | 19,419 | 19,419 | 82,152 |
| End Cash Position | 72,854 | 73,835 | 166,139 | 58,065 | 19,419 |
| Net Cash Flow | $53,435 | $54,416 | $146,720 | $38,646 | $-62,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205,134 | -142,442 | -101,927 | -65,292 | -158,889 |
| Capital Expenditure | -46,791 | -23,456 | -5,612 | -637 | -6,917 |
| Free Cash Flow | -251,925 | -165,898 | -107,539 | -65,929 | -165,806 |